Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:49 AM
Ignite Modification Date:
2025-12-25 @ 2:49 AM
NCT ID:
NCT04161833
Eligibility Criteria:
Inclusion Criteria:
* 18 years or older
* Karnofsky performance score≥70
* Indication for AI treatment in adjuvant setting for breast cancer
* Arthralgia with grade ≥0-1
Exclusion Criteria:
* Concomitant diseases, e.g. diabetes, renal insufficiency, alcohol abuse
* Concomitant rheumatological disease (Rheumatoid arthritis, Spondyloarthropathies, Psoriatic arthritis, etc.)
* Concomitant endocrinological disease (Acromegaly , Emocromatosis, etc)
* Any conditions that would complicate arthralgia assessment (e.g. Trauma, Glucocorticoid withdrawal, Hypertrophic osteoarthropathy, Osteoarthritis, Avascular necrosis, Gout, Systemic lupus erythematosus, Septic arthritis, etc.)
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT04161833
Study Brief:
Protocol Section:
NCT04161833